Obstructive Sleep Apnea of Adult Clinical Trial
Official title:
Combining Sonography to Explore the Therapeutic Effect and Mechanism of a Comprehensive Respiratory Training Exercise Program on Cardiorespiratory Endurance and Airway Muscle Function in Obstructive Sleep Apnea
NCT number | NCT05739617 |
Other study ID # | A-BR-111-079 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | March 1, 2023 |
Est. completion date | March 2026 |
Obstructive sleep apnea (OSA) is a multi-factorial sleep disorder. Complete collapse or partial collapse in the airway increases the risk of developing cardiovascular and kidney-related disease in OSA patients. Resulting in an increase in medical expenses and workload for the healthcare worker. Multilevel of upper airway muscles especially the genioglossus muscle showed to contribute to airway obstruction as it fatigues easily. The endurance level of OSA patients was shown to be significantly lower. Therefore, the goal of this experimental study is to assess the feasibility and effectiveness of a comprehensive respiratory training exercise program on cardiorespiratory endurance, airway muscle function, and sleep parameters in patients with obstructive sleep apnea (OSA). Aside from exploring the therapeutic effect, the results of the study will be used to explore the mechanism of the treatment in relation to the changes in the OSA severity.
Status | Recruiting |
Enrollment | 150 |
Est. completion date | March 2026 |
Est. primary completion date | December 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 65 Years |
Eligibility | Inclusion Criteria: - Newly diagnosed with OSA (AHI= 5 events per hour) - Age between 20 to 65 years old - BMI of 18-30 kg.m-2 Exclusion Criteria: Diagnosed with any of the following diseases below: - Central or mixed types of sleep apnea - Neuromuscular disease - Severe cardiovascular disease - Active psychiatric disease - Head or neck disease or cancer - Structural abnormalities over the upper respiratory airway - Performed any operation or treatment over the neck before - Pregnancy |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Cheng Kung University Hospital | Tainan |
Lead Sponsor | Collaborator |
---|---|
National Cheng-Kung University Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Apnea-Hypopnea Index (AHI) | The apnea-hypopnea index will be obtained from the overnight Polysomnography (PSG) study. PSG will be performed in the sleep center of National Cheng Kung University Hospital. Less than 5 events/hour indicates normal; AHI between 5-14 events/hour indicates mild Obstructive Sleep Apnea(OSA); AHI between 15-30 events/hour indicates moderate OSA; and AHI more than 30 events/hour indicates severe OSA. | Baseline to 3 months (post-training) | |
Primary | Change in Oxygen Desaturation Index (ODI) | The average number of desaturation episodes per hour (oxygen desaturation index) will be obtained from the overnight Polysomnography (PSG) study. A decrease in the mean oxygen saturation of =4% that lasts for at least 10 seconds indicates an episode of desaturation. | Baseline to 3 months (post-training) | |
Primary | Change in Maximum Oxygen Consumption (Vo2max) | Maximum oxygen consumption (Vo2max) will be measured using Cardiopulmonary Exercise Testing (CPET) which will be performed on a static bicycle. The average value of Vo2max in adults is approximately 27-48 mL/kg/min. A greater Vo2max value indicates a better physical fitness level. | Baseline to 3 months (post-training) | |
Primary | Change in Tongue Muscle Thickness | Sonography will be performed over the participant's neck region to assess the changes in tongue muscle thickness during normal breathing, Müller's maneuver, functional tasks, and natural sleep.
The data on tongue thickness will be presented in millimeters. A greater value indicates a thicker in tongue. |
Baseline to 3 months (post-training) | |
Primary | Change in Tongue Muscle Stiffness | Ultrasound shear-wave elastography will be performed to assess the changes in tongue-based stiffness. The data will be presented in kPa, with a greater value indicating an increase in tongue stiffness. The minimum value is 0 kPa and the maximum value is 220 kPa. | Baseline to 3 months (post-training) | |
Primary | Change in Tongue Muscle Strength | The tongue muscle strength will be measured using an Iowa Oral Performance Instrument (IOPI) device, model 2.2 (Northwest, Co., LLC, Carnation, WA, USA). The minimum score is 0 and a higher score indicates stronger in tongue muscle strength. | Baseline to 3 months (post-training) | |
Primary | Change in Tongue Muscle Endurance | The tongue muscle endurance will be measured using an Iowa Oral Performance Instrument (IOPI) device, model 2.2 (Northwest, Co., LLC, Carnation, WA, USA). The data will be presented in seconds. The longer the duration of holding (more than 10 seconds), the greater in the tongue muscle endurance. | Baseline to 3 months (post-training) | |
Primary | Change in Jaw strength | Jaw strength will be measured using a 'handheld' dynamometer (MicroFET?R2, Hoggan Scientific, USA). The data will be presented in kilogram-weight. The minimum score is 0 and a higher score indicates stronger in jaw strength. | Baseline to 3 months (post-training) | |
Primary | Change in Pharyngeal Airway Volume | Computer Tomography (CT) will be performed. The pharyngeal airway volume will be calculated from the hard palate to the epiglottis and the data will be presented in cm3. The minimum score is 0 and a higher score indicates greater in pharyngeal airway volume. | Baseline to 3 months (post-training) | |
Primary | Change in Cross Section Area on the Tip of Epiglottis | Computer Tomography (CT) will be performed. Cross section area on the tip of the epiglottis was measured and the data will be presented in cm2. The minimum score is 0 and a higher score indicates greater in the cross-sectional area of the region. | Baseline to 3 months (post-training) | |
Primary | Change in Anterior to Posterior Distance on the Tip of the Epiglottis | The distance between the anterior and posterior pharyngeal wall on the tip of the epiglottis will be measured and presented in cm. The minimal value will be 0 and the greater value indicates a greater distance between the anterior to posterior in this area. | Baseline to 3 months (post-training) | |
Primary | Change in Lateral Distance on the Tip of Epiglottis | The distance between the lateral distance on the tip of the epiglottis will be measured and presented in cm. The minimal value will be 0 and the greater value indicates a greater distance between the lateral wall. | Baseline to 3 months (post-training) | |
Primary | Change in daytime sleepiness | Epworth Sleepiness Score(ESS) will be used to measure the daytime sleepiness of OSA patients. The total score of ESS range from 0-24. A score greater than 10 indicates greater daytime sleepiness. | Baseline to 3 months (post-training) | |
Primary | Change in Drug-induced Sleep Endoscopy (DISE) | The level of obstruction, the degree of obstruction, and the configuration of the obstructive will be identified through the drug-induced sleep endoscopy. The degree of obstruction ranged from 0 to 2. 0: no obstruction; 1: partial obstruction; 2: complete obstruction. | Baseline to 3 months (post-training) | |
Primary | Change in sleep quality | Sleep quality will be measured using Pittsburgh Sleep Quality Index (PSQI).The total score ranges from 0 to 21 with a higher total score equal to or more than 5 indicating worse sleep quality. | Baseline to 3 months (post-training) | |
Secondary | Change in Maximal Inspiratory Pressure (PImax) | For respiratory muscle strength, maximal inspiratory pressure (PImax) will be measured using Respiratory Pressure Meter. Data will be presented in cmH2O. The minimal score will be 0, and a higher value indicates stronger in the inspiratory muscle. | Baseline to 3 months (post-training) | |
Secondary | Change in Maximal Expiratory Pressure (PEmax) | For respiratory muscle strength, maximal expiratory pressure (PEmax) will be measured using Respiratory Pressure Meter. Data will be presented in cmH2O. The minimal score will be 0, and a higher value indicates stronger in the expiratory muscle. | Baseline to 3 months (post-training) | |
Secondary | Change in forced vital capacity (FVC) % predicted | The respiratory muscle function on the forced vital capacity (FVC) % predicted will be collected using spirometry. The normal value is between 80% to 120%; mild abnormality: is 70-79%; moderate abnormality: is 60-69%; severe abnormality: is less than 60%. | Baseline to 3 months (post-training) | |
Secondary | Change in Forced Expiratory Volume in one second (FEV1)/ forced vital capacity(FVC) % | The respiratory muscle function on the Forced Expiratory Volume in one second (FEV1)/ forced vital capacity(FVC) will be collected using spirometry. The normal value for the FEV1/FVC % is equal to or greater than 70%; mild abnormality: 60-69%; moderate abnormality: 50-59%; severe abnormality: less than 50%. | Baseline to 3 months (post-training) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05489562 -
Use of Intraoral Suction and Its Effects on Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT05717959 -
Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device
|
N/A | |
Recruiting |
NCT06008626 -
Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT03122639 -
Endothelial Function in Obstructive Sleep Apnea
|
Early Phase 1 | |
Completed |
NCT03940781 -
Effects of Rehabilitation for Patients With Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT05289063 -
Vascular Endothelial Dysfunction in Sleep Apnea
|
Phase 1 | |
Not yet recruiting |
NCT05268471 -
Cost-effectiveness Analysis and Conditional Response to the Effect of Positional Devices in Obstructive Sleep Apnea
|
N/A | |
Active, not recruiting |
NCT04864652 -
Safety and Dosing Study of the CHILLS Cryotherapy for the Treatment of OSA
|
N/A | |
Enrolling by invitation |
NCT05433883 -
The Relationship Between Obstructive Sleep Apnea and Alzheimer's Disease: Evidence and Effectiveness
|
N/A | |
Recruiting |
NCT06103630 -
Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device
|
N/A | |
Recruiting |
NCT06283095 -
Management of Obstructive Sleep Apnea Syndrome by Expansion Palatoplasty
|
N/A | |
Completed |
NCT03156283 -
SleepWell24: An Innovative Smartphone Application to Improve PAP Adherence
|
N/A | |
Completed |
NCT03362385 -
OSA-ACS Project: Association of OSA and CPAP Therapy With Outcomes in ACS Patients
|
||
Recruiting |
NCT06447818 -
Changes in Difficult Airway Markers After Surgery for Obstructive Sleep Apnoea Syndrome
|
||
Completed |
NCT04643782 -
Comparative Study of the ANNE™ One System to Diagnose Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT03463785 -
Does Race Make a Difference in Obstructive Sleep Apnea?
|
||
Recruiting |
NCT03618719 -
Impact of Intermittent Hypoxia on the Function of the Phagocytes
|
||
Completed |
NCT03048604 -
BiLAteral Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnoea (BLAST OSA)
|
N/A | |
Recruiting |
NCT05290350 -
Long COVID-19 Fatigue and Obstructive Sleep Apnea
|
||
Completed |
NCT03980158 -
Change in Tongue Strength and Fatigue After Upper Airway Stimulation Therapy
|